BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Jan 16, 15:50Prev. Close
92.71
Open Price
92.71
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Par Drugs & Chemicals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 10.86 | 11.78 | 9.21 | 7.49 | 18.87 | |
| Diluted EPS (Rs.) | 10.86 | 11.78 | 9.21 | 7.49 | 18.87 | |
| Cash EPS (Rs.) | 13.82 | 14.58 | 11.84 | 10.15 | 23.46 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 80.44 | 69.59 | 57.90 | 48.66 | 84.87 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 80.44 | 69.59 | 57.90 | 48.66 | 84.87 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 1.25 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 82.06 | 77.73 | 77.82 | 61.01 | 98.75 | |
| PBDIT/Share (Rs.) | 17.60 | 18.74 | 14.99 | 13.36 | 26.34 | |
| PBIT/Share (Rs.) | 14.63 | 15.95 | 12.36 | 10.69 | 21.75 | |
| PBT/Share (Rs.) | 14.57 | 15.86 | 12.25 | 10.32 | 20.71 | |
| Net Profit/Share (Rs.) | 10.86 | 11.79 | 9.21 | 7.49 | 18.87 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 21.44 | 24.11 | 19.26 | 21.89 | 26.66 | |
| PBIT Margin (%) | 17.83 | 20.51 | 15.88 | 17.52 | 22.02 | |
| PBT Margin (%) | 17.75 | 20.40 | 15.74 | 16.92 | 20.97 | |
| Net Profit Margin (%) | 13.22 | 15.16 | 11.83 | 12.27 | 19.11 | |
| Return on Networth / Equity (%) | 13.49 | 16.93 | 15.91 | 15.38 | 22.23 | |
| Return on Capital Employed (%) | 17.51 | 22.00 | 20.31 | 20.61 | 22.15 | |
| Return on Assets (%) | 11.18 | 14.27 | 12.75 | 11.70 | 15.20 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | |
| Asset Turnover Ratio (%) | 0.91 | 1.00 | 1.14 | 0.97 | 0.89 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 3.31 | 4.79 | 3.53 | 2.93 | 2.58 | |
| Quick Ratio (X) | 2.94 | 4.46 | 3.15 | 2.61 | 2.39 | |
| Inventory Turnover Ratio (X) | 19.64 | 6.97 | 8.13 | 7.68 | 7.47 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 16.69 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 12.31 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 83.31 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 87.69 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 76.93 | 228.45 | 150.02 | 180.36 | 62.64 | |
| EV/Net Operating Revenue (X) | 0.76 | 2.39 | 1.57 | 2.40 | 1.03 | |
| EV/EBITDA (X) | 3.55 | 9.91 | 8.13 | 10.97 | 3.87 | |
| MarketCap/Net Operating Revenue (X) | 1.03 | 2.77 | 1.80 | 2.62 | 1.25 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 83.30 | 0.00 | |
| Price/BV (X) | 1.06 | 3.10 | 2.42 | 3.28 | 1.46 | |
| Price/Net Operating Revenue | 1.03 | 2.77 | 1.80 | 2.62 | 1.25 | |
| Earnings Yield | 0.13 | 0.05 | 0.07 | 0.05 | 0.15 |
27.11.2025
Par Drugs Standalone September 2025 Net Sales at Rs 28.66 crore, down 17.31% Y-o-Y
22.08.2025
Par Drugs Standalone June 2025 Net Sales at Rs 26.05 crore, up 15.22% Y-o-Y
12.05.2025
Par Drugs Standalone March 2025 Net Sales at Rs 22.33 crore, down 2.14% Y-o-Y
23.10.2024
Par Drugs Standalone September 2024 Net Sales at Rs 34.66 crore, up 33.88% Y-o-Y
15.03.2018
24.04.2017
24.04.2017
20.04.2017